Håkan Hedman Selected Research

Håkan Hedman Research Topics

Disease

23	Neoplasms (Cancer) 01/2021 - 07/2003
8	Glioma (Gliomas) 02/2018 - 01/2002
4	Breast Neoplasms (Breast Cancer) 05/2020 - 01/2005
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2019 - 07/2003
3	Lung Neoplasms (Lung Cancer) 11/2018 - 07/2003
3	Carcinoma (Carcinomatosis) 01/2017 - 07/2003
3	Glioblastoma (Glioblastoma Multiforme) 09/2013 - 08/2004
3	Oligodendroglioma 07/2012 - 08/2004
2	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2014
2	Carcinogenesis 01/2021 - 01/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 09/2014
2	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 06/2011
2	Adenocarcinoma 01/2013 - 07/2003
2	Astrocytoma (Pilocytic Astrocytoma) 07/2012 - 08/2004
2	Meningioma (Meningiomas) 07/2012 - 08/2004
2	Renal Cell Carcinoma (Grawitz Tumor) 05/2012 - 01/2004
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Urofacial syndrome 01/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2019
1	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2019
1	Heart Failure 01/2016
1	Body Weight (Weight, Body) 01/2016
1	Cardiomegaly (Heart Hypertrophy) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2014
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2014
1	Brain Neoplasms (Brain Tumor) 07/2012
1	Ependymoma 01/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2007
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2005
1	Hyperplasia 08/2004
1	Mesothelioma 07/2003

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2003
12	Leucine (L-Leucine)FDA Link 01/2021 - 03/2006
9	ErbB Receptors (EGF Receptor)IBA 01/2021 - 01/2004
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2014 - 03/2007
5	Messenger RNA (mRNA)IBA 01/2015 - 08/2004
3	Phosphotransferases (Kinase)IBA 11/2018 - 01/2015
3	tyrosine receptor (receptor, tyrosine)IBA 11/2018 - 01/2015
3	Biological ProductsIBA 06/2011 - 01/2005
2	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 02/2018 - 01/2013
2	Pharmaceutical PreparationsIBA 07/2012 - 01/2002
2	SecretoglobinsIBA 04/2005 - 07/2003
2	CaspasesIBA 01/2004 - 01/2002
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	NetrinsIBA 01/2021
1	Netrin-1IBA 01/2021
1	Steroid Receptors (Steroid Receptor)IBA 05/2020
1	heparanaseIBA 01/2019
1	Platelet-Derived Growth FactorIBA 02/2018
1	Polyvinyl Chloride (PVC)IBA 01/2017
1	HDL LipoproteinsIBA 01/2016
1	HDL CholesterolIBA 01/2016
1	N-propionylprocainamideIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Indicators and Reagents (Reagents)IBA 06/2014
1	epidermal growth factor receptor VIIIIBA 09/2013
1	Vorinostat FDA Link 07/2012
1	Estrogen ReceptorsIBA 07/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2012
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2012
1	Bortezomib (Velcade)FDA Link 07/2012
1	Histone Deacetylase InhibitorsIBA 07/2012
1	Proteasome InhibitorsIBA 07/2012
1	4-phenylbutyric acid (Buphenyl)FDA Link 07/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 07/2012
1	Vinorelbine (Navelbine)FDA LinkGeneric 01/2012
1	Cisplatin (Platino)FDA LinkGeneric 01/2012
1	Docetaxel (Taxotere)FDA Link 01/2012
1	AndrogensIBA 06/2011
1	Growth Factor ReceptorsIBA 02/2011
1	Hormones (Hormone)IBA 04/2005
1	Caspase 9IBA 01/2004
1	Caspase 3 (Caspase-3)IBA 01/2004
1	Caspase 8 (Caspase-8)IBA 01/2004
1	Apoptosis Regulatory ProteinsIBA 01/2004
1	UteroglobinIBA 07/2003
1	Estramustine FDA Link 01/2002

Therapy/Procedure

1	Therapeutics 01/2004